Our relentless dedication to develop therapeutics for eradicating solid tumors is driven by our commitment to save lives and address the world’s most pressing healthcare needs.
We have carried out a number of global first and world-leading clinical trials of CAR-T, to provide patients with safe and effective CAR-T therapy, to help patients and their families overcome cancer is our constant mission.
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the U.S. FDA
June 19, 2019
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the NMPA
March 01, 2019
CARsgen Therapeutics Receives IND Clearance for GPC3-CAR-T Cells from the NMPA
January 29, 2019
1F, Building 2, NO.466 Yindu Road.Xuhui District,Shanghai.P.R.China.200231
Copyright 2015-2020 CARsgen Therapeutics | All Rights Reserved
Shanghai ICP 16036549 Shanghai Public Network Security 31010402003200